Cel-Sci Corporation

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
150837607
SEDOL
BDFZC26
CIK
0000725363
cel-sci.com
LEI:
©
FIGI: BBG000H5G6L5
CVM
Cel-Sci Corporation
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
AI
PROFILER
NAME
Cel-Sci Corporation
ISIN
US1508376076
TICKER
CVM
MIC
XASE
REUTERS
CVM.N
BLOOMBERG
CVM US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Wed, 04.09.2024

Original-Research: CEL-SCI Corporation - from First Berlin Equity Research GmbH 04.09.2024 / 12:31 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conc...
Research & Analysis
Read more
Tue, 11.06.2024

Original-Research: CEL-SCI Corporation - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to CEL-SCI Corporation Company Name: CEL-SCI Corporation ISIN: US1508376076 Reason for the research: Update Recommendation: Buy from: 11.06.2024 Target price: USD 6.20 Target price on sight of: 12 months Last rating c...
Research & Analysis
Read more
Wed, 14.02.2024

Original-Research: CEL-SCI Corporation - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu CEL-SCI Corporation Unternehmen: CEL-SCI Corporation ISIN: US1508376076 Anlass der Studie: Update Empfehlung: Buy seit: 14.02.2024 Kursziel: USD 8.40 Kursziel auf Sicht von: 12 months Letzte Ratingänderung: - Analyst: ...
Research & Analysis
Read more
Tue, 05.12.2023

Original-Research: CEL-SCI Corporation - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu CEL-SCI Corporation Unternehmen: CEL-SCI Corporation ISIN: US1508376076 Anlass der Studie: Initiation of coverage Empfehlung: Buy seit: 05.12.2023 Kursziel: USD8.40 Kursziel auf Sicht von: 12 months Letzte Ratingänderu...
Research & Analysis
Read more
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S